{{Rsnum
|rsid=1109324
|Chromosome=6
|position=43762018
|Orientation=minus
|GMAF=0.1286
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
}}{{PharmGKB
|RSID=rs1109324
|Name_s=
|Gene_s=VEGFA
|Feature=
|Evidence=PubMed ID:17319747
|Annotation=This variant in the promoter region of the VEGFA gene was associated with increased risk for bladder cancer in a large-scale evaluation study of SNPs in candidate genes for cancer in 1,086 cases and 1,033 controls in Spain.
|Drugs=
|Drug Classes=
|Diseases=Urinary Bladder Neoplasms
|Curation Level=Curated
|PharmGKB Accession ID=PA162355805
}}

{{PMID Auto
|PMID=22315135
|Title=The single-nucleotide polymorphisms +936 C/T VEGF and -710 C/T VEGFR1 are associated with breast cancer protection in a Spanish population
}}

{{PMID Auto
|PMID=19064790
|Title=Predictive genomics of cardioembolic stroke.
|OA=1
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs1109324
|overall_frequency_n=11
|overall_frequency_d=128
|overall_frequency=0.0859375
|n_genomes=11
|n_genomes_annotated=0
|n_haplomes=12
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=2
|webscore=N
|n_web_uneval=10
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}